Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system

Department of Medicine, Queen Mary Hospital, Hong Kong, People's Republic of China.

OBJECTIVES: The objectives of this study were 1) to evaluate the effect of different right atrial electrode locations on the efficacy of low energy transvenous defibrillation with an implantable lead system; and 2) to qualitate and quantify the discomfort from atrial defibrillation shocks delivered by a clinically relevant method. BACKGROUND: Biatrial shocks result in the lowest thresholds for transvenous atrial defibrillation, but the optimal right atrial and coronary sinus electrode locations for defibrillation efficacy in humans have not been defined. METHODS: Twenty-eight patients (17 men, 11 women) with chronic atrial fibrillation (AF) (lasting > or = 1 month) were studied. Transvenous atrial defibrillation was performed by delivering R wave-synchronized biphasic shocks with incremental shock levels (from 180 to 400 V in steps of 40 V). Different electrode location combinations were used and tested randomly: the anterolateral, inferomedial right atrium or high right atrial appendage to the distal coronary sinus. Defibrillation thresholds were defined in duplicate by using the step-up protocol. Pain perception of shock delivery was assessed by using a purpose-designed questionnaire; sedation was given when the shock level was unacceptable (tolerability threshold). RESULTS: Sinus rhythm was restored in 26 of 28 patients by using at least one of the right atrial electrode locations tested. The conversion rate with the anterolateral right atrial location (21 [81%] of 26) was higher than that with the inferomedial right atrial location (8 [50%] of 16, p < 0.05) but similar to that with the high right atrial appendage location (16 [89%] of 18, p > 0.05). The mean defibrillation thresholds for the high right atrial appendage, anterolateral right atrium and inferomedial right atrium were all significantly different with respect to energy (3.9 +/- 1.8 J vs. 4.6 +/- 1.8 J vs. 6.0 +/- 1.7 J, respectively, p < 0.05) and voltage (317 +/- 77 V vs. 348 +/- 70 V vs. 396 +/- 66 V, respectively, p < 0.05). Patients tolerated a mean of 3.4 +/- 2 shocks with a tolerability threshold of 255 +/- 60 V, 2.5 +/- 1.3 J. CONCLUSIONS: Low energy transvenous defibrillation with an implantable defibrillation lead system is an effective treatment for AF. Most patients can tolerate two to three shocks, and, when the starting shock level (180 V) is close to the defibrillation threshold, they can tolerate on average a shock level of 260 V without sedation. Electrodes should be positioned in the distal coronary sinus and in the high right atrial appendage to achieve the lowest defibrillation threshold, although other locations may be suitable for certain patients.

This article has been cited by other articles:

				S. J. Walsh, G. Manoharan, O. J. Escalona, J. Santos, N. Evans, J. McC. Anderson, M. Stevenson, J. D. Allen, and A.A. J. Adgey Novel rectangular biphasic and monophasic waveforms delivered by a radiofrequency-powered defibrillator compared with conventional capacitor-based waveforms in transvenous cardioversion of atrial fibrillation. Europace, October 1, 2006; 8(10): 873 - 880. [Abstract] [Full Text] [PDF]

				J. Baumert, C. Schmitt, and K.-H. Ladwig Psychophysiologic and Affective Parameters Associated With Pain Intensity of Cardiac Cardioverter Defibrillator Shock Discharges Psychosom Med, July 1, 2006; 68(4): 591 - 597. [Abstract] [Full Text] [PDF]

				J.C. Geller, S. Reek, C. Timmermans, T. Kayser, H.-F. Tse, C. Wolpert, W. Jung, A.J. Camm, C.-P. Lau, H. J.J. Wellens, et al. Treatment of atrial fibrillation with an implantable atrial defibrillator -- long term results Eur. Heart J., December 1, 2003; 24(23): 2083 - 2089. [Abstract] [Full Text] [PDF]

				T. H. Everett IV, J. G. Akar, L.-C. Kok, J. R. Moorman, and D. E. Haines Use of global atrial fibrillation organization to optimize the success of burst pace termination J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1831 - 1840. [Abstract] [Full Text] [PDF]

				I. Mirza, S. James, and P. Holt Biatrial pacing for paroxysmal atrial fibrillation: A randomized prospective study into the suppression of paroxysmal atrial fibrillation using biatrial pacing J. Am. Coll. Cardiol., August 7, 2002; 40(3): 457 - 463. [Abstract] [Full Text] [PDF]

				G. Lehmann, J. Horcher, K. Dennig, A. Plewan, K. Ulm, and E. Alt Atrial Mechanical Performance After Internal and External Cardioversion of Atrial Fibrillation : An Echocardiographic Study Chest, January 1, 2002; 121(1): 13 - 18. [Abstract] [Full Text] [PDF]

				A. R. J. Mitchell, P. A. R. Spurrell, K. Kamalvand, M. Higson, R. Shanmuganathan, N. R. Patel, and N. Sulke What is the optimal electrode configuration for atrial defibrillators in man? Europace, January 1, 2002; 4(1): 41 - 44. [Full Text] [PDF]

				P.E. Vardas, E.G. Manios, E.M. Kanoupakis, D.N. Dermitzaki, H.E. Mavrakis, and E.M. Kallergis Atrial defibrillation threshold in humans minutes after atrial fibrillation induction. 'a stitch in time saves nine' Eur. Heart J., September 1, 2001; 22(17): 1613 - 1617. [Abstract] [PDF]

				X. Zheng, M. E. Benser, G. P. Walcott, and R. E. Ideker Right Atrial Septal Electrode for Reducing the Atrial Defibrillation Threshold Circulation, August 28, 2001; 104(9): 1066 - 1070. [Abstract] [Full Text] [PDF]

				T. H. Everett IV, J. R. Moorman, L.-C. Kok, J. G. Akar, and D. E. Haines Assessment of Global Atrial Fibrillation Organization to Optimize Timing of Atrial Defibrillation Circulation, June 12, 2001; 103(23): 2857 - 2861. [Abstract] [Full Text] [PDF]

				E. G. Daoud, C. Timmermans, C. Fellows, R. Hoyt, R. Lemery, K. Dawson, and G. M. Ayers Initial Clinical Experience With Ambulatory Use of an Implantable Atrial Defibrillator for Conversion of Atrial Fibrillation Circulation, September 19, 2000; 102(12): 1407 - 1413. [Abstract] [Full Text] [PDF]

				R. Ammer, G.u. Lehmann, A. Plewan, K. Puetter, and E. Alt Marked reduction in atrial defibrillation thresholds with repeated internal cardioversion J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1569 - 1576. [Abstract] [Full Text] [PDF]

				C. Timmermans, A. Nabar, L.-M. Rodriguez, G. Ayers, and H. J. J. Wellens Use of Sedation During Cardioversion With the Implantable Atrial Defibrillator Circulation, October 5, 1999; 100(14): 1499 - 1501. [Abstract] [Full Text] [PDF]

				H.-F. Tse, C.-P. Lau, B. M. Yomtov, and G. M. Ayers Implantable atrial defibrillator with a single-pass dual-electrode lead J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1974 - 1980. [Abstract] [Full Text] [PDF]

				C. Timmermans, L.-M. Rodriguez, G. M. Ayers, H. Lambert, J. L. R. M. Smeets, J. W. S. Vlaeyen, A. Albert, and H. J. J. Wellens Effect of Butorphanol Tartrate on Shock-Related Discomfort During Internal Atrial Defibrillation Circulation, April 13, 1999; 99(14): 1837 - 1842. [Abstract] [Full Text] [PDF]

				C.-P. Lau, H.-F. Tse, and G. M. Ayers Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1217 - 1226. [Abstract] [Full Text] [PDF]

				H. J. J. Wellens, C.-P. Lau, B. Luderitz, M. Akhtar, A. L. Waldo, A. J. Camm, C. Timmermans, H.-F. Tse, W. Jung, L. Jordaens, et al. Atrioverter: An Implantable Device for the Treatment of Atrial Fibrillation Circulation, October 20, 1998; 98(16): 1651 - 1656. [Abstract] [Full Text] [PDF]

				A. L. Waldo Low-Energy Atrial Defibrillation : A Promising New Technique Circulation, September 1, 1998; 98(9): 833 - 834. [Full Text] [PDF]